Merrick B A, Davies M H, Cook D E, Holcslaw T L, Schnell R C
Pharmacology. 1985;30(3):129-35. doi: 10.1159/000138061.
Experiments were conducted to determine if substrate-specific changes in microsomal metabolism and liver proteins occurred in young (12-13 weeks) spontaneously hypertensive rats (SHR) fed ad libitum compared to age-matched normotensive Wistar Kyoto (WKY) control rats. The hepatic microsomal protein content in SHR rats was significantly increased compared to WKY rats while cytosolic and total liver protein levels did not differ between the two groups. Liver microsomal ethylmorphine-N-demethylase activity was substantially enhanced in SHR rats with only slight increases in cytochrome P-450 content and aniline hydroxylase activity compared to WKY rats. The substrate-specific increases in the microsomal drug metabolism in SHR rats were accompanied by an increase in the prominence of a protein with molecular weight 55,000 in the cytochrome P-450 region. These preliminary observations may be clinically relevant in that alterations in hepatic drug metabolism may be associated with endogenous biochemical processes underlying the hypertensive state.
进行实验以确定,与年龄匹配的正常血压Wistar Kyoto(WKY)对照大鼠相比,自由采食的年轻(12 - 13周)自发性高血压大鼠(SHR)的微粒体代谢和肝脏蛋白质是否发生底物特异性变化。与WKY大鼠相比,SHR大鼠肝脏微粒体蛋白含量显著增加,而两组间胞质和肝脏总蛋白水平无差异。与WKY大鼠相比,SHR大鼠肝脏微粒体乙基吗啡 - N - 脱甲基酶活性显著增强,细胞色素P - 450含量和苯胺羟化酶活性仅略有增加。SHR大鼠微粒体药物代谢的底物特异性增加伴随着细胞色素P - 450区域中分子量为55,000的蛋白质的突出程度增加。这些初步观察结果可能具有临床相关性,因为肝脏药物代谢的改变可能与高血压状态潜在的内源性生化过程有关。